These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 1379664

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study.
    Fonseca E, Grau JJ, Sastre J, García-Gómez JM, Rueda A, Pastor M, Lara MA, Navalón M, Berrocal A, Tisaire JL, Cruz JJ.
    Eur J Cancer; 2005 Jun; 41(9):1254-60. PubMed ID: 15908196
    [Abstract] [Full Text] [Related]

  • 43. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study.
    King GW, Halpin JJ, Smith RE, Batley F, Schuller DE.
    Cancer Treat Rep; 1979 Jun; 63(11-12):1735-8. PubMed ID: 93508
    [Abstract] [Full Text] [Related]

  • 44. Vinorelbine, bleomycin and methotrexate as a salvage therapy for patients with head and neck squamous carcinoma in relapse after cisplatin/fluorouracil.
    Iop A, Cartei G, Isaia A.
    Ann Oncol; 1998 Feb; 9(2):225-7. PubMed ID: 9553671
    [Abstract] [Full Text] [Related]

  • 45. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
    Caradonna R, Paladine W, Ruckdeschel JC, Goldstein JC, Olson JE, Jaski JW, Silvers SA, Hillinger S, Horton J.
    Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
    [No Abstract] [Full Text] [Related]

  • 46. Folinic acid plus 5-FU based chemotherapy in squamous cell carcinoma of the head and neck: Bologna experience.
    Pannuti F, Guaraldi M, Martoni A, Melotti B, Morritti MG.
    Ann Oncol; 1993 Mar; 4 Suppl 2():45-8. PubMed ID: 7688983
    [Abstract] [Full Text] [Related]

  • 47. A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck.
    Abele R, Honegger HP, Grossenbacher R, Mermillod B, Kaplan E, Gervasi A, Wolfensberger M, Lehmann W, Cavalli F.
    Eur J Cancer Clin Oncol; 1987 Jan; 23(1):47-53. PubMed ID: 2439344
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil.
    Amrein PC, Weitzman SA.
    J Clin Oncol; 1985 Dec; 3(12):1632-9. PubMed ID: 2415693
    [Abstract] [Full Text] [Related]

  • 51. Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region.
    Fountzilas G, Daniilidis J, Sridhar KS, Kalogera-Fountzila A, Zaramboukas T, Sombolos K, Destouni-Salem E, Vritsios A, Tourkantonis A.
    Cancer; 1990 Oct 01; 66(7):1453-60. PubMed ID: 1698526
    [Abstract] [Full Text] [Related]

  • 52. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
    Vokes EE, Schilsky RL, Weichselbaum RR, Guaspari A, Guarnieri CM, Whaling SM, Panje WR.
    Cancer; 1989 Mar 15; 63(6 Suppl):1048-53. PubMed ID: 2783881
    [Abstract] [Full Text] [Related]

  • 53. Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck.
    Vogl SE, Komisar A, Kaplan BH, Engstrom PF, Kasule OH, Stolbach L, Lerner H, Muggia F.
    Cancer; 1986 Feb 15; 57(4):706-10. PubMed ID: 2417680
    [Abstract] [Full Text] [Related]

  • 54. Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.
    Vokes EE, Choi KE, Schilsky RL, Moran WJ, Guarnieri CM, Weichselbaum RR, Panje WR.
    J Clin Oncol; 1988 Apr 15; 6(4):618-26. PubMed ID: 3258629
    [Abstract] [Full Text] [Related]

  • 55. Methotrexate and leucovorin double-modulated 5-fluorouracil combined with cisplatin (MPFL) in metastatic/recurrent head and neck cancer.
    Chang PM, Teng HW, Chen PM, Chang SY, Chu PY, Tsai TL, Tai SK, Wang YF, Huang JL, Yang MH.
    J Chin Med Assoc; 2008 Jul 15; 71(7):336-41. PubMed ID: 18653395
    [Abstract] [Full Text] [Related]

  • 56. [Evaluation of multidisciplinary treatment involving chemotherapy with cis-diamminedichloroplatinum, bleomycin (peplomycin) and 5-fluorouracil for advanced esophageal carcinoma].
    Nakamura J, Nasu H, Masamune O, Inoue Y.
    Nihon Gan Chiryo Gakkai Shi; 1990 May 20; 25(5):939-45. PubMed ID: 1697321
    [Abstract] [Full Text] [Related]

  • 57. Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer.
    Browman GP, Archibald SD, Young JE, Hryniuk WM, Russell R, Kiehl K, Levine MN.
    J Clin Oncol; 1983 Dec 20; 1(12):787-92. PubMed ID: 6366132
    [Abstract] [Full Text] [Related]

  • 58. Report of an early stopped randomized trial comparing cisplatin vs. cisplatin/ifosfamide/ 5-fluorouracil in recurrent cervical cancer.
    Cadron I, Jakobsen A, Vergote I.
    Gynecol Obstet Invest; 2005 Dec 20; 59(3):126-9. PubMed ID: 15604591
    [Abstract] [Full Text] [Related]

  • 59. Carboplatin/5-fluorouracil as an alternative to cisplatin/5- fluorouracil for metastatic and recurrent head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Kua VF, Ismail F, Chee Ee Phua V, Aslan NM.
    Asian Pac J Cancer Prev; 2013 Dec 20; 14(2):1121-6. PubMed ID: 23621198
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.